diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) by mutation analysis. Prenat Diagn 2005; 25:1057.440 440. Konialis C, Hagnefelt B, Kokkali G, et al. Pregnancy following preimplantation genetic diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Prenat Diagn 2007; 27:1079.
441 441. Middleton A, Hewison J, Mueller R. Prenatal diagnosis for inherited deafness: what is the potential demand? J Genet Couns 2001; 10:121.
442 442. Milunsky A, Alpert E, Kitzmiller JL, et al. Prenatal diagnosis of neural tube defects. VIII. The importance of serum α‐fetoprotein screening in diabetic pregnant women. Am J Obstet Gynecol 1982; 142:1030.
443 443. Miller E, Hare JW, Cloherty JP, et al. Elevated maternal HbA1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 1981; 304:1331.
444 444. McElvy SS, Miodovnik M, Rosenn B, et al. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med 2000; 9:14.
445 445. Penney GC, Mair G, Pearson DW, et al. Outcomes of pregnancies in women with type 1 diabetes in Scotland: a national population‐based study. Br J Obstet Gynaecol 2003; 110:315.
446 446. Stormdal Bring H, Hultén Varli IA, Kublickas M, et al. Causes of stillbirth at different gestational ages in singleton pregnancies. Acta Obstet Gynecol Scand 2014; 93:86.
447 447. Kropff J, Selwood MP, McCarthy MI, et al. Prevalence of monogenic diabetes in young adults: a community‐based, cross‐sectional study in Oxfordshire, UK. Diabetologia 2011; 54:1261.
448 448. Pihoker C, Gilliam LK, Ellard S, et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab 2013; 98:4055.
449 449. Kleinberger JW, Maloney KA, Pollin TI. The genetic architecture of diabetes in pregnancy: implications for clinical practice. Am J Perinatol 2016; 33:1319.
450 450. Stein SA, Maloney KL, Pollin TI. Genetic counseling for diabetes mellitus. Curr Genet Med Rep 2014; 2:56.
451 451. Dickens LT, Naylor RN. Clinical management of women with monogenic diabetes during pregnancy. Curr Diab Rep 2018; 188:12.
452 452. Shields BM, Hicks S, Shepherd MH, et al. Maturity‐onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 2010; 53(12):2504.
453 453. Colstrup M, Mathiesen ER, Damm P, et al. Pregnancy in women with type 1 diabetes: have the goals of St. Vincent declaration been met concerning foetal and neonatal complications? J Matern Fetal Neonatal Med 2013; 26:1682.
454 454. Schaefer‐Graf U, Napoli A, Nolan CJ. Diabetes in pregnancy: a new decade of challenges ahead. Diabetologia 2018; 61:1012.
455 455. Parimi M, Nitsch D. A systemic review and meta‐analysis of diabetes during pregnancy and congenital genitourinary abnormalities. Kidney Int Rep 2020; 5:678.
456 456. Mackin ST, Nelson SM, Kerssens JJ, et al. Diabetes and pregnancy: national trends over 15 year period. Diabetologia 2018; 61:1081.
457 457. Helle E, Priest JR. Maternal obesity and diabetes mellitus as risk factors for congenital heart disease in the offspring. J Am Heart Assoc 2020; 9:e011541.
458 458. Stogianni A, Lendahls L, Landin‐Olsson M, et al. Obstetric and perinatal outcomes in pregnancies complicated by diabetes, and control pregnancies, in Kronoberg, Sweden. BMC Pregnancy Childbirth 2019; 19:159.
459 459. Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun 2019; 96:1.
460 460. Limaye MA, Buyon JP, Cuneo BF, et al. A review of fetal and neonatal consequences of maternal systemic lupus erythematosus. Prenat Diagn 2020; 40:1066.
461 461. Popescu MR, Dudu A, Jurcut C, et al. A broader perspective on Anti‐Ro antibodies and their fetal consequences – a case report and literature review. Diagnostics (Basel) 2020; 10:478.
462 462. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349:1526.
463 463. Satoh M, Chan EK, Ho LA, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum 2012; 64:2319.
464 464. Wainwright B, Bhan R, Trad C, et al. Autoimmune‐mediated congenital heart block. Best Pract Res Clin Obstet Gynaecol 2020; 64:41.
465 465. Panaitescu AM, Nicolaides K. Maternal autoimmune disorders and fetal defects. J Matern Fetal Neonatal Med 2018; 31:1798.
466 466. Brito‐Zerón P, Izmirly PM, Ramos‐Casals M, et al. The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol 2015; 11:301.
467 467. Clowse ME, Eudy AM, Kiernan E, et al. The prevention, screening and treatment of congenital heart block from neonatal lupus:a survey of provider practices. Rheumatology 2018; 57(Suppl S5):v9.
468 468. Rein AJJT, Mevorach D, Perles Z, et al. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti‐SSA/Ro‐SSB/La antibodies a prospective, observational, fetal kinetocardiogram‐based study. Circulation 2009; 119:1867.
469 469. Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS Guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019; 74:932.
470 470. Stanner C, Horndasch M, Vitanova K, et al. Neonates and infants requiring life‐long cardiac pacing: How reliable are epicardial leads through childhood? Int J Cardiol 2019; 297:43.
471 471. Izmirly PM, Costedoat‐Chalumeau N, Pisoni CN, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti‐SSA/ro‐antibody – Associated cardiac manifestations of neonatal lupus. Circulation 2012; 126:76.
472 472. Hansahiranwadee W. Diagnosis and management of fetal autoimmune atrioventricular block. Int J Womens Health 2020; 12:633.
473 473. Pruetz JD, Miller JC, Loeb GE, et al. Prenatal diagnosis and management of congenital complete heart block. Birth Defects Res 2019; 111:380.
474 474. Thomas NS, Durkie M, Van Zyl B, et al. Parental and chromosomal origin of unbalanced de novo structural chromosome abnormalities in man. Hum Genet 2006; 119(4):444.
475 475. Thomas NS, Morris JK, Baptista J, et al. De novo apparently balanced translocations in man are predominantly paternal in origin and associated with a significant increase in paternal age. J Med Genet 2010; 47(2):112.
476 476. Teras LR, Gaudet MM, Blase JL, Gapstur SM. Parental Age at birth and risk of hematological malignancies in older adults. Am J Epidemiol 2015; 182(1):41.
477 477. Green RF, Devine O, Crider KS, et al. Association of paternal age and risk for major congenital anomalies from the National Birth Defects Prevention Study, 1997 to 2004. Ann Epidemiol 2010; 20(3):241.
478 478. World Health Organization. Towards more objectivity in diagnosis and management of male
